KalVista Pharmaceuticals, Inc.KALVNASDAQ
Loading
EBITDA as a percentage of revenue
Latest
-1272.15%
↓ 266% vs avg
Percentile
P8
Near historical low
Streak
1 yr
Consecutive declineContracting
Average
-347.34%
Historical baseline
| Period | Value | YoY Change |
|---|---|---|
| TTM | -1272.15% | - |
| 2025 | 0.00% | - |
| 2024 | 0.00% | - |
| 2023 | 0.00% | - |
| 2022 | 0.00% | - |
| 2021 | 0.00% | +100.0% |
| 2020 | -315.37% | -72.7% |
| 2019 | -182.56% | +17.3% |
| 2018 | -220.69% | +85.1% |
| 2017 | -1482.65% | - |